Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 24, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	195	84	59	77	65	47	Upgrade
Market Cap Growth	141.21%	43.08%	-23.75%	19.20%	38.44%	-34.64%	Upgrade
Last Close Price	21.50	8.40	5.03	5.42	4.46	3.17	Upgrade
PE Ratio	7.93	3.41	2.40	3.61	3.34	6.47	Upgrade
PS Ratio	3.21	1.39	0.99	1.41	1.31	1.64	Upgrade
PB Ratio	1.37	0.58	0.46	0.68	0.62	0.55	Upgrade
P/FCF Ratio	11.66	4.15	1.48	4.39	-	8.16	Upgrade
P/OCF Ratio	11.04	4.05	1.47	4.32	152.28	7.18	Upgrade
Debt / Equity Ratio	0.65	0.40	0.45	0.30	-	-	Upgrade
Debt / FCF Ratio	5.54	2.86	1.47	1.96	-	-	Upgrade
Return on Equity (ROE)	-	17.96%	20.21%	19.59%	20.33%	8.81%	Upgrade
Return on Assets (ROA)	-	2.10%	2.25%	2.17%	2.27%	0.98%	Upgrade
Earnings Yield	12.60%	29.29%	41.69%	27.70%	29.93%	15.46%	Upgrade
FCF Yield	8.58%	24.08%	67.67%	22.80%	-0.08%	12.25%	Upgrade
Dividend Yield	4.65%	-	19.88%	18.46%	-	-	Upgrade
Payout Ratio	36.90%	36.70%	36.90%	-	-	-	Upgrade
Buyback Yield / Dilution	6.12%	-	-	6.16%	1.79%	1.75%	Upgrade
Total Shareholder Return	10.77%	-	19.88%	24.62%	1.79%	1.75%	Upgrade

Source: S&P Global Market Intelligence. Banks template. Financial Sources.